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vention group. Anti-diarrheal and anti-microbial drugs
were dispensed in over 90% of the encounters, sometimes
with ORS. Slight improvement in knowledge was seen 
on some aspects after training. However, while ORS-only
was dispensed in fewer than 10% of encounters, around
20% of interviewees indicated they would dispense only
ORS for such case.
CONCLUSIONS: Despite slight improvement of knowl-
edge on some aspects of case management after training,
the program failed to improve practice. Better knowledge
does not necessarily lead to better practice.
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The formulary decision-making (FDM) process involves
many factors that must be considered in order to deter-
mine whether a speciﬁc drug product should be placed on
a formulary. Still, the frequency of use, and the need for
more information of the factors used in FDM is unknown
at this time.
OBJECTIVES: The objectives of this study were to iden-
tify: (1) which outcome measures, pharmacoeconomic
methodologies, and sources of information are used in the
FDM process, and (2) areas in which formulary decision-
makers require more information.
METHODS: A mail survey, based on the literature and
two focus groups held with pharmacists involved in
FDM, was developed in the summer of 2000. The ﬁnal
survey was mailed to 40 registrants to a FDM conference
(before the conference was held) and to 25 other phar-
macists involved in FDM in Atlantic Canada. Respon-
dents were asked to rate their organization’s use and their
personal need for more information of 27 different
factors, tools, and techniques. Data analysis was per-
formed using SumQuest Survey Software, v. 7.0. and JMP,
v. 3.2.1.
RESULTS: Thirty-nine of the 64 (60.9%) useable surveys
were completed and returned. Out of 14 outcome 
measures considered, relative efﬁcacy of the drugs was
identiﬁed as being the most frequently used, while
quality-adjusted life years was identiﬁed as being the least
frequently used. Cost-effectiveness analysis was identiﬁed
as being the most commonly used pharmacoeconomic
technique, while cost-consequence analysis was identiﬁed
as being the least frequently used. Cost-consequence
analysis was identiﬁed by the respondents as being their
single greatest learning need.
CONCLUSIONS: Traditional outcome measures such as
relative efﬁcacy and cost of the drug still appear to be the
main factors used in FDM in Atlantic Canada. The ﬁnd-
ings have provided an insight into the FDM process and
have identiﬁed topics for future continuing education
events.
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In response to increasing prescription costs, managed care
plans are adopting multi-tiered plans that shift medica-
tion costs to the consumer.
OBJECTIVE: To examine the impact of 2 and 3 tiered
plans on patient attitudes and behavior of individuals
with chronic diseases.
METHODS: Quasi-experimental pre-post with compari-
son group design was used for a sample with hyperten-
sion, dylipidemia, arthritis, GERD or diabetes. General
attitudes about formulary medications, factors affecting
the decision to switch to formulary medications and the
willingness-to-pay for non-formulary medications were
obtained from a mail survey administered in the pre
period. Intervention group included members whose
employer converted from a 2-tier to a 3-tier beneﬁt (n =
5,711). Comparison groups included members whose
employer remained in a 2-tier (n = 715) or 3-tier beneﬁt
(n = 1,707). Maximum likelihood estimates from a
repeated measures model were used to examine changes
in formulary compliance controlling for demographics,
health status, diseases, plan type and attitudes. Formulary
compliance rate (pre- versus post- intervention).
RESULTS: Formulary compliance showed a negligible
increase over time in individuals whose plans did not
change. Intervention group experienced a 5.6% increase
in formulary compliance rate (p < .0001). However their
baseline rates were 13% lower than their counterparts in
2-tier plans. Attitudinal measures had no effect on for-
mulary compliance rates. Individuals over 65 years and
those under 25 years were respectively 4.0% and 7.5%
more formulary compliant than those between 25–64
years. Differences existed by disease state: diabetics were
6.9% more compliant, while arthritics (2.8%), hyperten-
sives (2.5%), and members with GERD (6.3%) were less
formulary compliant.
CONCLUSIONS: 3 tier plans can improve formulary
compliance rates of individuals with chronic diseases.
Patient attitudes had no impact on formulary compliance.
Future research should investigate how 3-tier beneﬁts
inﬂuence medical resource utilization.
